Coxiron 60mg tablets

Ferron Par Pharmaceuticals

Ingredients in every tablet

Etoricoxib 60 mg

Each package contains

3 blisters of 10 tablets

Other details

Dosage form:Tablet; coated
Flavour: None

W.H.O. classification

ATC Level 1: M - Musculo-skeletal system
ATC Level 2: M01 - Antiinflammatory and Antirheumatic Products
ATC Level 3: M01A - Antiinflammatory and Antirheumatic Products; Non-Steroids



NOT SAFEThis item is not safe for use during pregnancy.


NOT SAFEThis item is not safe for use during lactation.


CONSULT YOUR DOCTORSafety of this item for use with alcohol has not been established. Please consult your doctor.


CONSULT YOUR DOCTORSafety of this item for use while operating heavy machinery has not been established. Please consult your doctor.

Available in


Dosage information

The recommended dose is 60 mg once daily.

Acute pain associated with dental surgery:
The recommended dose is 120 mg once daily. Etoricoxib 120 mg should be used only for the acute symptomatic period.

Chronic musculoskeletal pain:
The recommended dose is 60 mg once daily

Doses greater than those recommended for each indication have either not demonstrated additional efficacy or have not been studied. Therefore, the dose for each indication is the maximum recommended dose.

Etoricoxib is administered orally. Etoricoxib may be taken with or without food.

No dosage adjustment in etoricoxib is necessary for the elderly or based on gender or race.

In patients with mild hepatic insufficiency (Child-Pugh score 5-6), a dose of 60 mg once daily should not be exceeded. In patients with moderate hepatic insufficiency (Child-Pugh score 7-9), the dose should be reduced; a dose of 60 mg every other day should not be exceeded, administration of 30 mg once daily can also be considered.
There are no clinical or pharmacokinetic data in patients with severe hepatic insufficiency (Child-Pugh score >9)

In patients with advanced renal disease (creatinine clearance <30 ml/min), treatment with etoricoxib is not recommended. No dosage adjustment is necessary for patients with lesser degrees of renal insufficiency (creatinine clearance ≥30 ml/min)


Etoricoxib is indicated for:
Symptomatic relief in the treatment of osteoarthritis (OA). (I p.1, II p.54, III p.1, IV p.1)
Relief of chronic musculoskeletal pain. (I, III p.1)
Relief of acute pain associated with dental surgery. (I, III p.1, IV p.1)


The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for informational purposes only. This tool may not cover all possible drug interactions or all warnings or alerts. Please check with a physician if you have health questions or concerns about interactions or go to the appropriate government authority for a comprehensive list of medical warnings. Although we attempt to provide accurate and up-to-date information, no guarantee is made to that effect.

All of the content present on this website, including written text, photographs, videos, graphics, and other resources we might include (these will fall under the collective term of “website”), is meant to educate and should not be perceived as a substitution for professional medical advice, diagnosis or treatment. You should not resort to the website information to arrive at a diagnosis or treatment solution for your health problems or various medical conditions. It does not replace medical care, provided by a medical specialist. In the situation, you have specific symptoms and you might suspect that you are suffering from a medical problem, it is for the best to consult your physician.